Financial Performance - The company's operating revenue for Q3 2022 was ¥855,055,322.73, a decrease of 0.73% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2022 was ¥8,275,730.15, down 87.21% year-on-year[6]. - The net profit after deducting non-recurring gains and losses was ¥7,056,616.37, a decline of 89.25% compared to the previous year[6]. - Basic earnings per share for Q3 2022 were ¥0.0187, reflecting an 87.21% decrease year-on-year[6]. - Total operating revenue for the third quarter of 2022 was CNY 2,664,182,457.51, a slight increase from CNY 2,650,707,735.25 in the same period last year, representing a growth of approximately 0.51%[27]. - Net profit for the third quarter was CNY 24,476,518.94, a significant decrease from CNY 151,066,581.01 in the previous year, reflecting a decline of approximately 83.8%[29]. - Earnings per share (EPS) for the quarter was CNY 0.0396, down from CNY 0.3576 in the same quarter last year, indicating a decrease of about 88.9%[32]. - The total comprehensive income for the quarter was CNY 12,312,617.30, a decrease from CNY 131,188,157.50 in the previous year, indicating a decline of approximately 90.6%[31]. Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥6,881,965,605.32, representing a 0.46% increase from the end of the previous year[6]. - As of September 30, 2022, the total assets amounted to RMB 6.88 billion, with total liabilities of RMB 1.72 billion[21]. - Total liabilities increased to CNY 3,287,892,107.41 from CNY 3,231,949,582.30, showing a rise of approximately 1.74%[27]. - The company's total equity decreased to CNY 3,594,073,497.91 from CNY 3,618,801,780.49, a decline of about 0.69%[27]. Cash Flow - The cash inflow from operating activities totaled CNY 2,934,414,025.59, a decrease of 5.7% compared to CNY 3,111,132,217.54 in the previous period[36]. - The net cash flow from operating activities was CNY 179,722,537.15, down from CNY 377,669,779.50 in the previous period, indicating a decline of 52.4%[36]. - The cash outflow from investing activities was CNY 607,941,873.40, significantly lower than CNY 1,888,274,393.57 in the previous period, reflecting a decrease of 67.8%[36]. - The net cash flow from financing activities was negative at CNY -195,199,820.88, contrasting with a positive CNY 157,587,743.46 in the previous period[36]. - The total cash and cash equivalents at the end of the period stood at CNY 425,479,603.99, compared to CNY 286,221,453.70 at the end of the previous period, representing an increase of 48.7%[36]. Expenses - Total operating costs increased to CNY 2,666,217,159.79 from CNY 2,527,089,634.33, marking an increase of about 5.5% year-over-year[29]. - Research and development expenses for the quarter were CNY 84,305,069.55, compared to CNY 76,091,484.03 in the previous year, reflecting an increase of approximately 10.3%[29]. - Sales expenses rose to CNY 1,135,229,353.22 from CNY 1,026,385,864.76, indicating an increase of about 10.6% year-over-year[29]. - The cash outflow for employee payments was CNY 591,203,203.73, an increase of 8.3% from CNY 545,925,592.19 in the previous period[36]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 78,376, with the largest shareholder, Shen Dongri, holding 47.82% of shares[15]. - The company has a total of 2.13% shares held by the third phase employee stock ownership plan, indicating employee engagement in the company's growth[15]. Investments and Acquisitions - The company's cash acquisition of 75% equity in Kunming Hancheng Medical Beauty Hospital was valued at approximately RMB 158.11 million, based on an assessment report[19]. - The company plans to expand its market presence through the acquisition of Kunming Hancheng, enhancing its operational capabilities in the medical beauty sector[19]. Other Financial Metrics - Non-operating income included government subsidies of ¥789,837.97, with total non-recurring gains and losses amounting to ¥1,219,113.78 for the quarter[7]. - The company reported a significant increase in construction in progress, rising 183.66% to ¥72,842,281.79 due to renovations[11]. - Financial expenses increased by 36.29% to ¥61,390,898.59, primarily due to increased loan interest expenses[11]. - The company experienced an 88.18% decrease in trading financial assets, totaling ¥20,000,000.00, mainly due to the redemption of financial products[11]. - The company reported accounts receivable of RMB 244.33 million, a slight decrease from RMB 253.87 million in the previous period[23]. - Inventory increased significantly from RMB 1.03 billion to RMB 1.22 billion over the same period, indicating a growth of approximately 18.1%[23]. - The company's short-term borrowings rose from RMB 658.85 million to RMB 793.50 million, reflecting an increase of about 20.4%[23]. - The total non-current assets increased from RMB 4.70 billion to RMB 4.79 billion, showing a growth of approximately 1.8%[23].
朗姿股份(002612) - 2022 Q3 - 季度财报